NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

8601	Companies
140529	Keywords
76494	Articles
75083	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 03/17/2025 at 21:15, 20 days 11 hours ago

NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu’à mi-2026
Nanobiotix renforce sa visibilité financière en amendant son accord de licence avec JNJ-1900 (NBTXR3), étendant son horizon de trésorerie jusqu’à mi-2026. Conférence le 18/03/2025

Trésorerie Accord De Licence NANOBIOTIX Visibilité Financière JNJ-1900
PRESS RELEASE

published on 03/17/2025 at 21:15, 20 days 11 hours ago

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
Nanobiotix strengthens financial position by amending global licensing agreement for JNJ-1900 (NBTXR3), extending cash visibility to mid-2026. Details of the amendment and future potential milestone payments outlined

Financial Position Milestone Payments NANOBIOTIX JNJ-1900 Global Licensing Agreement
BRIEF

published on 03/13/2025 at 22:20, 24 days 10 hours ago

Nanobiotix publie les détails de ses droits de vote et de son capital social

Euronext Paris Droit De Vote Transparence Financière Actions En Circulation NANOBIOTIX
BRIEF

published on 03/13/2025 at 22:20, 24 days 10 hours ago

Nanobiotix Reports Voting Rights and Share Capital Details

Euronext Paris Voting Rights Financial Transparency NANOBIOTIX Shares Outstanding
PRESS RELEASE

published on 03/13/2025 at 22:15, 24 days 10 hours ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix communique sur le nombre total d'actions et de droits de vote. Informations boursières et présentation de l'entreprise de biotechnologie

Droits De Vote Euronext Biotechnologie Actions NANOBIOTIX
PRESS RELEASE

published on 03/13/2025 at 22:15, 24 days 10 hours ago

Voting Rights and Shares Capital of the Company
Nanobiotix reports voting rights and shares capital. Detailed breakdown of outstanding shares and voting rights presented. Company overview and contact information included

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 02/12/2025 at 22:20, 1 month 22 days ago

Nanobiotix : Détails sur les Droits de Vote et Actions en Janvier 2025

Euronext Paris Droits De Vote Actions Nasdaq NANOBIOTIX
BRIEF

published on 02/12/2025 at 22:20, 1 month 22 days ago

Nanobiotix: Details on Voting Rights and Shares in January 2025

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 02/12/2025 at 22:15, 1 month 22 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix announces voting rights and shares capital details. Company listed on Euronext Paris and Nasdaq. Focus on disruptive therapeutic approaches

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE

published on 02/12/2025 at 22:15, 1 month 22 days ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Communiqué mensuel de Nanobiotix sur les droits de vote et actions. Informations financières conformes à la règlementation des marchés financiers. Nanobiotix, société de biotechnologie, cotée à Euronext Paris et Nasdaq, développe des traitements innovants

Euronext Paris Biotechnologie Nasdaq NANOBIOTIX Traitements Innovants

Accesswire

Published on 04/07/2025 at 08:00, 55 minutes ago

Pulsar Helium Announces Notice of 2025 Annual General and Special Meeting of Shareholders
Published on 04/07/2025 at 00:05, 8 hours 50 minutes ago

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 05:50, 2 days 3 hours ago

Lobe Sciences Provides Corporate Update
Published on 04/05/2025 at 01:50, 2 days 7 hours ago

Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/05/2025 at 01:00, 2 days 7 hours ago

AIML Announces Proposed Private Placement

View all ACCESSWIRE

EQS Group

Published on 04/07/2025 at 08:48, 6 minutes ago

Twin Sails Interactive: TWIN SAILS INTERACTIVE PREND SON INDÉPENDANCE D'ASMODEE
Published on 04/07/2025 at 08:35, 20 minutes ago

Eurobattery Minerals receives assessment report regarding the CRMA application for Hautalampi and is invited to reapply
Published on 04/07/2025 at 08:00, 54 minutes ago

Cairn Homes Plc: Issue of Equity for Vesting of share awards under the Cairn Homes plc Long Term Incentive Plan
Published on 04/07/2025 at 08:00, 55 minutes ago

Transaction in Own Shares
Published on 04/07/2025 at 08:00, 55 minutes ago

Transactions in Own Shares

Les Echos

Published on 04/07/2025 at 07:01, 1 hour 54 minutes ago

bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 1 hour 54 minutes ago

bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 13 hours ago

Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 13 hours ago

Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 14 hours ago

Reporting on share buyback transactions carried out between March 31 and April 3, 2025

View all LES ECHOS COMFI WIRE